Federated Hermes’s DNA X Inc SONM Stock Holding History

Federated Hermes’s Portfolio SONM Stock Details SONM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1	Closed	-$1K	–	2341
2020 Q4	$1K	Hold	1	–	–	﹤0.01%	2189
2020 Q3	$1K	Hold	1	–	–	﹤0.01%	2190
2020 Q2	$2K	Buy	+1	New	+$1.6K	﹤0.01%	2094

Other funds holding SONM

BRF

B. Riley Financial Los Angeles, California $456M AUM 896.07% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Harvey Partners Tarrytown, New York $1.26B AUM 64.44% 1-Year Est. Return

MHP

Manatuck Hill Partners Westport, Connecticut $370M AUM 95.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

USPCM

Union Square Park Capital Management New York $176M AUM 51.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Federated Hermes's SONM Position: Q1 2021 in Review

Federated Hermes sold out of DNA X Inc (SONM) in Q1 2021, closing a stake of 1 share — an estimated $1K sold.

Federated Hermes first reported a position in SONM in Q2 2020 and held it in 3 quarters. The position peaked at $2K in Q2 2020. 23 funds tracked by Wall St. Rank hold SONM as of Q1 2021.

Federated Hermes reported no remaining DNA X Inc position as of Q1 2021 after selling out during the quarter.
Federated Hermes sold 1 DNA X Inc share in Q1 2021, an estimated $1K.
Federated Hermes first reported a position in DNA X Inc in Q2 2020 and held it in 3 quarters.
Federated Hermes's DNA X Inc position peaked at $2K in Q2 2020.
23 funds tracked by Wall St. Rank held DNA X Inc as of Q1 2021.

Based on Federated Hermes's 13F filing for Q1 2021, filed 13 May 2021.